BDRX News and Press, Biodexa Pharmaceuticals PLC-ADR From 07/11/25

Unity Bancorp Inc. (UNTY) is expected to report $1.16 for Q2 2025 Aeon Co. Ltd. ADR (AONNY) is expected to report for Q1 2026 Asante Gold Corp (ASGOF) is expected to report for Q1 2026 Evergreen Corporation (EVGR) is expected to report for quarter end 2025-05-31 null (EGRVF) is ex...

2025-07-10 18:46:15 ET Biodexa Pharmaceuticals Plc (BDRX) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 12.41%. The average open to low on the day of earnings was -3.52%. The average o...

2025-07-10 18:41:15 ET Biodexa Pharmaceuticals Plc (BDRX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in BDRX stock price following earnings has averaged ±2.82% , with a median of 2.1...

June 25, 2025 Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company de...

June 23, 2025 Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipel...

CARDIFF, UNITED KINGDOM / ACCESS Newswire / June 18, 2025 / When it comes to type 1 diabetes, treating this chronic condition can be difficult. After all, with this type of diabetes, the body's immune system attacks and destroys the beta cells that produce insulin. Without the natural ability ...

2025-06-17 14:00:34 ET Houston American Energy Rallies 89% Amid Elevated Crude Prices Houston American Energy Corp. ( HUSA ) soared 89.31% to lead the PRISM Emerging Oil & Gas Index as crude oil prices continue to climb. The rise follows sustained investor focus on geo...

June 4, 2025 Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of ...

May 30, 2025 Biodexa Pharmaceuticals PLC Shareholder Update Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of disease...

May 22, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment ...